Literature DB >> 30753591

Experimental Candida albicans osteomyelitis: Microbiologic, antigenic, histologic, and 18FDG-PET-CT imaging characteristics in a newly established rabbit model.

Maria N Gamaletsou1, Joseph Meletiadis2, Sofia Chatziioannou3,4, Ioannis G Panayiotides5, Euthimios Agadakos6, Michalis Katsimpoulas7, Nikolaos Kostomitsopoulos7, Vidmantas Petraitis8, Thomas J Walsh8,9,10, Nikolaos V Sipsas1.   

Abstract

Candida osteomyelitis is a debilitating disease that is difficult to diagnose and treat. As there are no animal models or prospective studies for this uncommon infection, little is known about the pathogenesis, diagnosis, or treatment. We therefore sought to establish an animal model for the study of the pathophysiology, diagnostic modalities, and therapeutic interventions of Candida osteomyelitis. We developed a modified version of the Norden rabbit model of tibial osteomyelitis, in which the right tibia was inoculated intraoperatively with different inocula of C. albicans or normal saline as control. On days 7, 14, and 21 after inoculation, the animals underwent bone radiography, 18-fluoro-2-deoxy-D-glucose positron emission tomography combined with computed tomography (PET/CT) scan, and blood sampling for blood cultures, blood counts, erythrocyte sedimentation rate, and Candida mannan antigen serum levels. On day 21, animals were euthanized, and infected tibias harvested for culture and histology. Among eight evaluable animals inoculated with 1 × 106 to 1 × 107 cfu, histology and bone cultures established the presence of Candida osteomyelitis in seven, with a host response of neutrophils, mononuclear cells, multinucleate giant cells, fibrosis, and necrosis. Infected animals demonstrated radiological signs of osteomyelitis with significantly increased tracer uptake in 18FDG-PET/CT scans (P < .01) and elevated serum mannan levels (P < .01). All blood cultures were negative. Indices of inflammation were only slightly increased. In conclusion, we report successful establishment of a new animal model of Candida albicans osteomyelitis that may be applicable to advancing our understanding of the pathophysiology, diagnostic modalities, and treatment of this debilitating infection.
© The Author(s) 2019. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Entities:  

Keywords:  experimental Candida albicans osteomyelitis

Year:  2019        PMID: 30753591     DOI: 10.1093/mmy/myz001

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  4 in total

1.  CT Imaging Characteristics and Influence Factors of Renal Dialysis-Associated Peritoneal Injury.

Authors:  Jin Tong; Wangda Xu
Journal:  J Healthc Eng       Date:  2021-04-20       Impact factor: 2.682

2.  Inhibition of Candida albicans in vivo and in vitro by antimicrobial peptides chromogranin A-N12 through microRNA-155/suppressor of cytokine signaling 1 axis.

Authors:  Xiaohua Li; Qun Hu; Qiong Lin; Jianxiong Luo; Junping Xu; Lifang Chen; Liyu Xu; Xin Lin
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

3.  Down-regulation of microRNA-155 suppressed Candida albicans induced acute lung injury by activating SOCS1 and inhibiting inflammation response.

Authors:  Xiaohua Li; Yuanzhong Gong; Xin Lin; Qiong Lin; Jianxiong Luo; Tianxing Yu; Junping Xu; Lifang Chen; Liyu Xu; Ying Hu
Journal:  J Microbiol       Date:  2022-02-14       Impact factor: 2.902

4.  Shape-Depended Biological Properties of Ag3PO4 Microparticles: Evaluation of Antimicrobial Properties and Cytotoxicity in In Vitro Model-Safety Assessment of Potential Clinical Usage.

Authors:  Karol P Steckiewicz; Julia Zwara; Maciej Jaskiewicz; Szymon Kowalski; Wojciech Kamysz; Adriana Zaleska-Medynska; Iwona Inkielewicz-Stepniak
Journal:  Oxid Med Cell Longev       Date:  2019-11-20       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.